# Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases

> **NCT02557490** · PHASE4 · UNKNOWN · sponsor: **Zhu Xu** · enrollment: 100 (estimated)

## Conditions studied

- Colon Cancer Liver Metastasis

## Interventions

- **DRUG:** oxaliplatin and raltitrexed

## Key facts

- **NCT ID:** NCT02557490
- **Lead sponsor:** Zhu Xu
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-12
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02557490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02557490, "Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02557490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*